Capital Flow Monitor · Sponsors · CIK 1973954
Kaida BioPharma Inc.
416 SW 1ST AVENUE, FORT LAUDERDALE, FL, 33301 · (917) 683-3092
Biotechnology · Corporation· inc. DELAWARE true 2022
Fit score
—
Offering
$4.1M
Sold
$1.6M
% sold
39.0%
Investors
44
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-09-01 | D/A ·current | 506(b) | $4.1M | $1.6M | 39.0% | 44 | EDGAR ↗ |
| 2026-01-21 | D | 506(b) | $3.0M | $1.6M | 52.4% | 42 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Craig Pierson — Executive Officer / Director, Fort Lauderdale, FL
-
Stella Vnook — Director, Fort Lauderdale, FL
2 other raises
- FIREFLY NEUROSCIENCE, INC. $2.3M of $20.3M · 11.1%
- Firefly Neuroscience, Inc. $2.3M of $20.3M · 11.1%
-
Richard Warburg — Director, Fort Lauderdale, FL
2 other raises
- eLux Medical, Inc. $1.3M of $4.0M · 31.9%
- ZETAGEN THERAPEUTICS, INC. $12.9M of $13.0M · 99.3%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.